Elevate Health vs NovoCare Pharmacy
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Elevate Health
Best for Shoppers who want compounded or brand-name tirzepatide with payment plans and add-on therapiesStarting at $299/mo
NovoCare Pharmacy
Best for branded Wegovy at the lowest manufacturer-direct self-pay priceStarting at $149/mo
Side-by-Side Comparison
| Feature | Elevate Health | NovoCare Pharmacy |
|---|---|---|
| Overall Score | 6.9/10 | ✓8.7/10 |
| Starting Price | $299/mo | ✓$149/mo |
| Editorial Rating | 3.5 ★ /5 | ✓4.4 ★ /5 |
| Features | ✓8 features | 5 features |
| States Available | 0 | ✓50 |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Elevate Health
What we like
- Compounded semaglutide ($299/mo, from $158/mo on 12-month) and tirzepatide ($399/mo, from $248/mo)
- Also offers brand-name Zepbound (tirzepatide) plus NAD+, B12, and glutathione add-ons
- All supplies included; Affirm/Klarna payment plans available
- Full refund if you are not approved
- 35,000+ patients served
Watch-outs
- Month-to-month pricing is high ($299 sema / $399 tirz); the low rates require a 12-month commitment
- Pharmacy partner and prescribing medical group not named
- States of operation not published
- Not LegitScript-certified (no certification displayed)
- No standalone Terms of Service page (only Privacy, HIPAA, and a safety-information page)
NovoCare Pharmacy
What we like
- First-party Novo Nordisk pharmacy — the most authoritative branded Wegovy channel
- $199/mo intro pricing on Wegovy 0.25/0.5 mg starter doses (through 6/30/2026), the lowest brand self-pay price
- $349/mo standard self-pay is well below the ~$1,300/mo retail list price
- Ships to all 50 states with no telehealth-platform middleman fees
- Cold-chain logistics handled directly by Novo Nordisk
- Insurance-billing path available via the NovoCare savings program
- NEW $149/mo Wegovy pill (oral semaglutide tablets, 1.5/4 mg) self-pay tier — 4 mg rises to $199/mo after 8/31/2026
Watch-outs
- Wegovy only — no Ozempic, no tirzepatide, no compounded GLP-1
- Requires an existing Wegovy prescription — no prescribing clinicians or telehealth intake
- No clinical support included — your own prescriber handles titration and side effects
- Manufacturer-set pricing can change at any time
- $199 pen intro covers only the first 2 fills for new patients (through 6/30/2026); maintenance doses are $349/mo ($399 HD)
Our Verdict
NovoCare Pharmacy edges out Elevate Health with a higher overall score of 8.7/10 and is particularly strong for branded Wegovy at the lowest manufacturer-direct self-pay price. Elevate Health remains a solid alternative, especially if you're looking for Shoppers who want compounded or brand-name tirzepatide with payment plans and add-on therapies.
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Elevate Health and NovoCare Pharmacy head-to-heads in the same category.
- Elevate Health vs CoreAge Rx
- Elevate Health vs TrimRx
- Elevate Health vs Amazon One Medical
- NovoCare Pharmacy vs Vytora Health
- NovoCare Pharmacy vs Enhance MD
- NovoCare Pharmacy vs Noom Med
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.